You are the one who chose a grossly inappropriate
Post# of 72430
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
CTIX can't be compared to any small biotech that I know of, because I know of no other small biotech with 3 drugs in 4 clinical trials in 4 completely different areas of unmet needs, that has been attacked so viciously by shorts that it has a market cap of far less than one start-up biotech with a failed Alzheimer's drug in clinical trials (AXON).
Since you brought up the original flawed comparison, perhaps you can find another such company.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)